Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

A long-term carcinogenicity study was performed in rats (dosing duration of 104 weeks) at doses up to and including 75 mg/kg/day (450 mg/m2) for male rats and 100 mg/kg/day

(600 mg/m2) for female rats. These doses are approximately 1.8-fold and 2.4-fold higher than the maximum daily human dosage of 246 mg/m2. No evidence of carcinogenicity was observed with tramadol in male or female rats. A carcinogenicity study was also conducted in p53(+/-)-heterozygous mice (dosing duration of 26 weeks) at doses up to and including 150 mg/kg/day (450 mg/m2) for male and female mice. This dose is approximately 1.8-fold higher than the maximum daily human dosage of 246 mg/m2. No evidence of carcinogenicity was observed in male or female mice.

Source: FDA [Internet]. U.S. Food and Drug Administration. Available from: http://www.fda.gov/

Key value for chemical safety assessment

Justification for classification or non-classification

Additional information